ライフサイエンスコーパス: nitric oxide

1 n of iNOS and production of the free radical nitric oxide.

2 n, paralysis, prone positioning, and inhaled nitric oxide.

3 s low micromolar, or iNOS-derived, levels of nitric oxide.

4 thought to be targets of endothelium-derived nitric oxide.

5 thase expression and beta-cell production of nitric oxide.

6 of saturating solutions of CO (160 mum) and nitric oxide (100 mum).

7 hing (+30%), nitrous oxide emissions (+30%), nitric oxide (+66%) emissions, and ammonia volatilizatio

8 Understanding the function of nitric oxide, a lipophilic messenger in physiological pr

9 Locally generated nitric oxide activates the nitric oxide-sensitive cation

10 Here we show that the protective actions of nitric oxide against EMCV infection are selective for be

11 The therapeutic application of nitric oxide, an endogenous cellular signaling molecule,

12 d an increase in the inhibition of hydroxyl, nitric oxide and alpha-amylase, as well as a decrease in

13 rved in the high baseline fractional exhaled nitric oxide and blood eosinophil subgroups (207 mL [95%

14 50] for the high baseline fractional exhaled nitric oxide and blood eosinophil subgroups, respectivel

15 ich provides an oxygen-independent source of nitric oxide and can delay skeletal muscle fatigue.

16 le signaling processes such as production of nitric oxide and caveolae-mediated intracellular traffic

17 calmodulin nitrated at Tyr-138 produced more nitric oxide and did so more efficiently than WT calmodu

18 r that promotes vasorelaxation by increasing nitric oxide and downregulating endothelin-1 (ET-1) prod

19 view is to highlight the biologic effects of nitric oxide and hydrogen sulfide, their seemingly indis

20 l perfusion through vasodilation mediated by nitric oxide and hydrogen sulfide.

21 ich nanoparticles, oxidants that may destroy nitric oxide and impair endothelial function, but also l

22 re cytocidal activity against beta-cells via nitric oxide and induce autoimmune diabetes.

23 osation in response to exposure to both free nitric oxide and nitrosothiols (k (inact)/K(I) >= 5 m(-1

24 assessed innate immune indices (haptoglobin, nitric oxide and ovotransferrin concentrations, and haem

25 molecule generated from the reaction between nitric oxide and superoxide radicals, in impairing endot

26 ons in obese mice generated higher levels of nitric oxide and superoxide radicals, resulting in incre

27 roups and gasotransmitters (carbon monoxide, nitric oxide, and hydrogen sulfide).

28 n of nitrate to dinitrogen gas over nitrite, nitric oxide, and nitrous oxide.

29 NMDA receptors (NMDARs) play a role through nitric oxide, and the CBF increase produced by endotheli

30 data point towards haemoglobin scavenging of nitric oxide as a key regulatory factor of brachial flow

31 cterization revealed that in the presence of nitric oxide as a spin probe and oxygen surrogate, both

32 S), 2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide assays.

33 gonorrhoeae blocks exfoliation by producing nitric oxide at the bacterial-host cell interface to pro

34 al at the ovule triggers the accumulation of nitric oxide at the filiform apparatus in a process that

35 itively, release of the vasodilator molecule nitric oxide attenuated endothelial TRPV4 channel activi

36 (1-methylnicotinamide, +33%; P=6.1x10(-67)), nitric oxide bioavailability (arginine/ornithine + citru

37 We hypothesized that low nitric oxide bioavailability due to the presence of cell

38 microvascular vasoreactivity, due to reduced nitric oxide bioavailability.

39 CI, -32.9%, -10.2%), and fractional exhaled nitric oxide, CCL26 and SERPINB2 mRNA expression in bron

40 oline receptors and are mediated through the nitric oxide/cGMP/protein kinase G pathway.

41 trogenase inactivation; and Glb1-1 modulates nitric oxide concentration during symbiosis, from the ea

42 One immune index, nitric oxide concentration showed a weak quadratic patte

43 to -0.77]) and had lower fractional exhaled nitric oxide concentrations (13.9 vs. 24.4 ppb; P < 0.00

44 sis following IGF-1 treatment, adenosine and nitric oxide contributed to hypoxia-mediated coronary va

45 rpose of this study was to determine whether nitric oxide contributes to the beta-cell response to vi

46 off axonal actin polymerization, mediated by nitric oxide-cyclic GMP signaling leading to inhibition

47 ), and at least 2 conditions associated with nitric oxide deficiency (diabetes, hypertension, obesity

48 tify glutamatergic signaling dysfunction and nitric oxide deficiency as yet-undescribed early manifes

49 n fraction (HFpEF) is often characterized by nitric oxide deficiency.

50 microbial nitrosative stress resistance and nitric oxide degradation.

51 ting mitochondrial oxidative metabolism in a nitric oxide-dependent manner.

52 Furthermore, BFM improved nitric oxide-dependent vasorelaxation induced by acetylc

53 We show here in C. elegans that nitric oxide derived from resident bacteria promotes wid

54 Collectively, these results suggest that nitric oxide-derived oxidants may causatively link nucle

55 lobins are cytoplasmic proteins required for nitric oxide detoxification and nitrosative stress resis

56 els and lung function and fractional exhaled nitric oxide did not differ by BMI category.

57 ADP-ribosylation reactions using a chemical nitric oxide donor S-nitrosoglutathione and enzymatic AD

58 um nitroprusside, an endothelium-independent nitric oxide donor.

59 itrite, which may subsequently be reduced to nitric oxide during conditions of hypoxia and in the pre

60 reduced production of the potent vasodilator nitric oxide during glutamatergic synaptic activity.

61 Specifically, nitric oxide emissions (NO) lead to increased smog, acid

62 f nitrate leaching, nitrous oxide emissions, nitric oxide emissions, and ammonia volatilization total

63 ctivity, characterised by the measurement of nitric oxide, endothelin-1, tissue plasminogen activator

64 The fractional exhaled nitric oxide (F(E) NO) is a marker for type 2 inflammati

65 lammation was assessed by fractional exhaled nitric oxide (FeNO) and exhaled breath condensate pH and

66 icosteroid adherence, and fractional exhaled nitric oxide (FeNO) in 17 studies for inhaled corticoste

67 Fraction of exhaled nitric oxide (FeNO) is a marker of eosinophilic airway i

68 t 2013 and February 2015, fractional exhaled nitric oxide (FeNO) was measured from 112 participants a

69 >=150/300 cells/uL and/or fractional exhaled nitric oxide [FeNO] >=25 ppb), annualized severe exacerb

70 oped iron sulfide nanoclusters that catalyse nitric oxide generation from benign sodium nitrite in th

71 This nitric oxide generation platform may advance mechanistic

72 rotein 2 in vitro decreased NOS3 expression, nitric oxide generation, and angiogenesis.

73 e involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.

74 unoblotting, proximity ligation as-says, and nitric oxide imaging, we report that phosphorylation of

75 s (RSNOs) serve as air-stable reservoirs for nitric oxide in biology.

76 ion of micromolar levels of the free radical nitric oxide in neighboring beta-cells.

77 y advance mechanistic studies of the role of nitric oxide in the nervous system and other organs.

78 The in situ generation of nitric oxide in the ventral tegmental area with the elec

79 we develop a step towards protocell-mediated nitric-oxide-induced vasodilation by constructing a new

80 We have recently shown that nitric oxide inhibits EMCV replication and EMCV-mediated

81 At these concentrations nitric oxide inhibits the Krebs enzyme aconitase and com

82 omuscular blockade, corticosteroids, inhaled nitric oxide (iNO), prone positioning, high-frequency os

83 b) and a 6 min inhalation of the vasodilator nitric oxide (iNO; 40 ppm in 21% O(2) ), to selectively

84 Preclinical models have demonstrated that nitric oxide is a key component of neurovascular couplin

85 Nitric oxide is a vital neurovascular signalling molecul

86 r coupling response by ~30%, indicating that nitric oxide is integral to neurovascular coupling in hu

87 d to cause cell death by virtue of releasing nitric oxide, is highly unstable in air and is rapidly o

88 odilatation and reduced resting steady-state nitric oxide levels in the blood Collectively, our data

89 ficantly correlated with fraction of exhaled nitric oxide levels.

90 es in line with temperate losses and raising nitric oxide losses above them.

91 erate and tropical croplands, although total nitric oxide losses were higher in the tropics.

92 monia, and pasture agroecosystems had higher nitric oxide losses.

93 ysed post hoc by baseline fractional exhaled nitric oxide (<35 and >=35 ppb) and blood eosinophil (<2

94 ed on a combination of tests including nasal nitric oxide measurement, transmission electron microsco

95 Ageing impaired nitric oxide-mediated EDD (peak EDD 88 +/- 12% 6 months

96 anoclusters with multimaterial fibres allows nitric oxide-mediated neuronal interrogation in vivo.

97 calization phenotype of these two mutants by nitric oxide-mediated/protein kinase G-dependent phospho

98 ge and are accompanied by alterations in the nitric oxide metabolism.

99 gh selectivities toward other enzymes of the nitric oxide-modulating system.

100 bolism, hepatic steatosis, oxidative stress, nitric oxide modulation, and collagen metabolism.

101 impact of various nitrogen oxides, including nitric oxide, nitrogen dioxide, and nitrous oxide, on ca

102 Nitric oxide nitrosates both precursor and mature forms

103 Protein S-nitrosylation, the nitric oxide (NO(*))-mediated posttranslational modifica

104 Nitric oxide (NO(-)) is a member of RNS produced from ar

105 emed to be endothelium dependent, as well as nitric oxide (NO) and guanylyl cyclase, but not prostagl

106 genomic approaches, we provide evidence that nitric oxide (NO) and oxylipin signalling pathways in di

107 A subset of these TFs is targeted each by nitric oxide (NO) and the phytochrome-interacting TF PIL

108 of evidence demonstrating that scavenging of nitric oxide (NO) and the reduction of nitrate/nitrite r

109 ction, due at least in part to reductions in nitric oxide (NO) bioavailability and associated vascula

110 onths of RT on sleep quality, redox balance, nitric oxide (NO) bioavailability, inflammation profile,

111 triction (FGR), due in part to reductions in nitric oxide (NO) bioavailability.

112 ickle cell disease (SCD), due in part to low nitric oxide (NO) bioavailability.

113 al-mediated routes for nitrite (NO(2)(-)) to nitric oxide (NO) conversion and phenol oxidation are of

114 discovered that KSHV hijacks the citrulline-nitric oxide (NO) cycle to promote growth proliferation

115 Constant therapeutic gas phase nitric oxide (NO) delivery is achieved from S-nitrosothi

116 cle, cytoglobin (Cygb) functions as a potent nitric oxide (NO) dioxygenase and regulates NO metabolis

117 Nitric oxide (NO) emerged as a key signal molecule in pl

118 ed with HbA1c and negatively correlated with nitric oxide (NO) in diabetic patients.

119 Real-time sensing of nitric oxide (NO) in physiological environments is criti

120 Chemical generation of nitric oxide (NO) in the absence of immune cells was suf

121 The short-lived hydrophobic gas nitric oxide (NO) is a broadly conserved signaling molec

122 Nitric oxide (NO) is a gaseous signaling molecule that p

123 Nitric oxide (NO) is a gasotransmitter with important ph

124 Nitric oxide (NO) is a gasotransmitter with important ro

125 Nitric oxide (NO) is a key signaling molecule that regul

126 Nitric oxide (NO) is a molecule of vast physiological si

127 Nitric oxide (NO) is a ubiquitous gaseous messenger, but

128 Nitric oxide (NO) is an important free radical synthesiz

129 Nitric oxide (NO) is an important signaling molecule tha

130 o investigate how the environmental stimulus nitric oxide (NO) is linked to biofilm dispersal, focusi

131 Nitric oxide (NO) is perfectly suited for the role of a

132 In addition, nitric oxide (NO) is produced from nitrate and nitrite,

133 a reduced growth and photosynthesis, altered nitric oxide (NO) level and leaf and root anatomy, inhib

134 n decompaction and increases oligodendrocyte nitric oxide (NO) levels.

135 reported concerning the effects of augmented nitric oxide (NO) on skeletal muscle force production an

136 dividual subunits, the KsNaxLS complex binds nitric oxide (NO) only at the distal heme side, forming

137 ransfer (PET) mechanism, we designed a smart nitric oxide (NO) probe, PYSNO, with high sensitivity an

138 Nitric oxide (NO) produced as a result of activation of

139 Nitric oxide (NO) produced by endothelial nitric oxide s

140 Here we demonstrate that nitric oxide (NO) produced by murine macrophages is resp

141 strated with pharmacological approaches that nitric oxide (NO) produced through the citrulline-NO pat

142 ntain mechanical strength, vasoactivity, and nitric oxide (NO) production for at least 4 weeks.

143 ically alters the transcriptome and triggers nitric oxide (NO) production in F. graminearum We identi

144 We observed nitric oxide (NO) production in human primary ECs stimul

145 ted with vascular complications and impaired nitric oxide (NO) production.

146 Nitric oxide (NO) regulates the deployment of a phalanx

147 controls pathogenesis via the regulation of nitric oxide (NO) resistance and inorganic nitrogen meta

148 Recombinant proteins were used to examine nitric oxide (NO) scavenging in vitro and transgenic pla

149 y-activated tumor cells, iNOS expression and nitric oxide (NO) secretion were significantly increased

150 sorders are associated with perturbations to nitric oxide (NO) signaling and impaired glucose metabol

151 Endothelial dysfunction and reduced nitric oxide (NO) signaling are a key element of the pat

152 Nitric oxide (NO) signaling has been studied in the eye,

153 e neighbor to human vasodilatory endothelial nitric oxide (NO) signaling.

154 Endothelial cell nitric oxide (NO) synthase (eNOS), the enzyme responsibl

155 Interepithelial transfer of exosomal nitric oxide (NO) synthase and nitric oxide was measured

156 ement was abolished by pretreatment with the nitric oxide (NO) synthase inhibitor l-N (G)-nitro-l-arg

157 S2) which instantly fills the phagosome with nitric oxide (NO) to clear the pathogen.

158 pecific tyrosine residues and interaction of nitric oxide (NO) with the P450 heme are necessary for N

159 mor-promoting and immunosuppressive molecule nitric oxide (NO), whereas macrophages largely express a

160 on product (APOP), myeloperoxidase (MPO) and nitric oxide (NO), while depleting levels of endogenous

161 uman cytochrome P450 (P450) CYP2B6 undergoes nitric oxide (NO)-dependent proteasomal degradation in r

162 Among molecules modulating the nitric oxide (NO)-GMP-phosphodiesterase (PDE) pathway, t

163 he transduction of endothelium-dependent and nitric oxide (NO)-mediated vasodilator activity, given i

164 Nitric oxide (NO)-NO-sensitive (soluble) guanylyl cyclas

165 ant version of ZIP and by treatment with the nitric oxide (NO)-synthase inhibitor L-NAME.

166 tron acceptors such as nitrite (NO(2)(-)) or nitric oxide (NO).

167 de synthase (eNOS), an enzyme that generates nitric oxide (NO).

168 ansmitter alongside carbon monoxide (CO) and nitric oxide (NO).

169 nia oxidizers by converting hydroxylamine to nitric oxide (NO).

170 ly sensitive to O(2) and highly sensitive to nitric oxide (NO).

171 mic haemodilution to assess the influence of nitric oxide on neurovascular coupling in humans.

172 ella strains induced apoptosis or stimulated nitric oxide or lactose dehydrogenase production in matu

173 e and S-nitroso-N-acetyl-d,l-penicillamine), nitric oxide, oxidized GSH, and hydrogen peroxide to pos

174 acorporeal membrane oxygenation, and inhaled nitric oxide; Pao2:Fio2 ratio measured daily from day 1

175 amate metabolism, dysfunctional arginine and nitric oxide pathways, and increased oxidative stress.

176 Like nitric oxide, pharmacological inhibition of mitochondria

177 activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD-media

178 suring mechanosensing, which is essential to nitric oxide production and flow-induced vasodilation.

179 ortance of the simultaneous consideration of nitric oxide production and inactivation when investigat

180 osure to high glucose, with the reduction in nitric oxide production being the most notable.

181 nal hyperemia by suppressing NMDAR-dependent nitric oxide production during neural activity.

182 factor alpha (TNF-alpha) mRNA and increased nitric oxide production during T. parva lethal infection

183 vessel wall shear stress and, consequently, nitric oxide production may contribute to heightened sys

184 , regulates permeability, leukocyte traffic, nitric oxide production, and coagulation, and harbors di

185 factor-kappaB (NF-kappaB) subunit p65, lower nitric oxide production, and diminished CHOP expression

186 ctivator of transcription (STAT) pathway and nitric oxide production, as well as the promotion of ade

187 ency prevents NMDA receptors from triggering nitric oxide production, thereby attenuating the flow in

188 Tyr-99 revealed that this nitration reduces nitric-oxide production and increases eNOS decoupling co

189 We show that nitric oxide protects beta-cells against virally mediate

190 The reduction of NO to N(2)O by flavodiiron nitric oxide reductases (FNORs) is related to the disrup

191 talloproteins related to beta-lactamases and nitric oxide reductases.

192 gulation, brain-derived neurotrophic factor, nitric oxide, renin-angiotensin).

193 sis revealed that endogenous accumulation of nitric oxide resulted in up-regulation of genes involved

194 The activity is critical in initiating a nitric oxide/S-nitrosylation-dependent signal transducti

195 This may be mediated through the nitric oxide scavenging potency of CFH, increasing basal

196 The presence of the nitric oxide-scavenging protein, haemoglobin alpha, limi

197 Locally generated nitric oxide activates the nitric oxide-sensitive cation channel, transient recepto

198 rescued F508del-CFTR by arginine-dependent, nitric oxide signaling through inhibition of endogenous

199 us-pituitary-adrenal axis; and adenosine and nitric oxide signaling.

200 Nitric oxide signalling is integral to NVC in humans, pr

201 Changes in haematocrit influence nitric oxide signalling through alterations in shear str

202 ipheral endothelial function, likely through nitric oxide signalling.

203 Akt Ser/Thr kinase, nitric oxide synthase 1, nitric oxide, soluble guanylate cyclase, cyclic GMP (cGM

204 in regulating cell growth and responding to nitric oxide stress in M. tuberculosis, but its underlyi

205 ime polymerase chain reaction of endothelial nitric oxide synthase (eNOS) and endothelin-1; (d) immun

206 ce K(+) (IK and SK) channels and endothelial nitric oxide synthase (eNOS) are present in the endothel

207 annels in some vascular beds and endothelial nitric oxide synthase (eNOS) in others.

208 Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) is a critical mediator of v

209 fragment of the shear-responsive endothelial nitric oxide synthase (eNOS) promoter, we tested effects

210 in (TM), a surface receptor, and endothelial nitric oxide synthase (eNOS), an enzyme that generates n

211 ated protein kinase (AMPK), Akt, endothelial nitric oxide synthase (eNOS), nuclear factor erythroid 2

212 skin wound angiogenesis through endothelial nitric oxide synthase (eNOS)-dependent Src, PI3K, and MA

213 and increased the phosphorylated endothelial nitric oxide synthase (eNOS)/eNOS ratio in an age-depend

214 PepNats representing hot loops of inducible nitric oxide synthase (iNOS) and human agouti-related pr

215 biomarkers include suppression of inducible nitric oxide synthase (iNOS) and induction of sterol reg

216 receptor (CB1R) and activation of inducible nitric oxide synthase (iNOS) are associated with nonalco

217 r of RNS produced from arginine by inducible Nitric Oxide Synthase (iNOS) enzyme.

218 s that are sufficient to stimulate inducible nitric oxide synthase (iNOS) expression and production o

219 showed that radiotherapy increased inducible nitric oxide synthase (iNOS) in the tumor tissues.

220 essions of interleukin (IL)-1beta, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, ma

221 ta); and the inflammatory markers: Inducible Nitric Oxide Synthase (iNOS), Interleukin 1beta (IL-1bet

222 ro-apoptotic signaling mediated by inducible nitric oxide synthase (iNOS), transforming growth factor

223 nylate-binding proteins (GBPs) and inducible nitric oxide synthase (iNOS), which we found to inhibit

224 d corneal allograft survival in an inducible nitric oxide synthase (iNOS)-dependent manner.

225 erythroid-derived 2)-like 2 (Nrf2), neuronal Nitric Oxide Synthase (nNOS) expression and nitrergic re

226 olves a tau-induced dissociation of neuronal nitric oxide synthase (nNOS) from postsynaptic density 9

227 Neuronal nitric oxide synthase (nNOS) regulates muscle atrophy in

228 In the course of our studies on neuronal nitric oxide synthase (nNOS), a client of the Hsp90 and

229 Inhibition of neuronal nitric oxide synthase (nNOS), an enzyme implicated in ne

230 ide synthase 1 adaptor protein) and neuronal nitric oxide synthase (nNOS), nNOS enzymatic activity, a

231 es calcium signals in pyramidal and neuronal nitric oxide synthase (nNOS)-expressing neurons.

232 rvalbumin, calbindin, calretinin, and neural nitric oxide synthase (nNOS).

233 od flow (FBF) response to acetylcholine, and nitric oxide synthase (NOS) activity was defined as the

234 erized further by triple labeling with CGRP, nitric oxide synthase (NOS) and calretinin (CALR) antibo

235 While NO production by nitric oxide synthase (NOS) enzymes in the eye has been

236 -like 2 (Nrf2)/tetrahydrobiopterin (BH(4) )/ nitric oxide synthase (NOS) expression in primary human

237 phorase is used as a histochemical marker of nitric oxide synthase (NOS) in aldehyde-treated tissues.

238 We investigated the role of nitric oxide synthase (NOS) in mediating blood-brain bar

239 Nitric oxide synthase (NOS) inhibitors rescue this patho

240 ermined by lactate dehydrogenase release and nitric oxide synthase (NOS)-dependent cGMP production.

241 ed STAT1 and its downstream target inducible nitric oxide synthase (NOS2) as being upregulated in the

242 Rs) on the host cell, it activates inducible nitric oxide synthase (NOS2) which instantly fills the p

243 FNgamma-dependent genes, including inducible nitric oxide synthase (Nos2).

244 The endothelial nitric oxide synthase (NOS3) system is crucial for vascu

245 hyperoxia-induced BPD and PH via endothelial nitric oxide synthase (NOS3).

246 nergy balance (e.g. oxytocin (OXT), neuronal nitric oxide synthase 1 (NOS1), melanocortin 4-receptor

247 e, including the interaction between NOS1AP (nitric oxide synthase 1 adaptor protein) and neuronal ni

248 tide 3-phosphate kinase, Akt Ser/Thr kinase, nitric oxide synthase 1, nitric oxide, soluble guanylate

249 Inbred mice that lack the gene encoding nitric oxide synthase 2 (Nos2) are susceptible to the re

250 infection, and testing MAIT cell priming in nitric oxide synthase 2 (NOS2)-deficient mice all failed

251 CXCL9/CXCL10), and innate immunity-related (nitric oxide synthase 2/inducible nitric oxide synthase

252 Nitric oxide synthase 2/inducible nitric oxide synthase

253 receptor agonist analog elicited endothelial nitric oxide synthase activation to promote endothelial

254 r arginase level and activity, and decreased nitric oxide synthase activity.

255 y-related (nitric oxide synthase 2/inducible nitric oxide synthase and IL-17C) products (FDR < 0.05).

256 ed distinct anti-inflammatory (low inducible nitric oxide synthase and lower tumour necrosis factor-a

257 Increased activities of inducible nitric oxide synthase and NADPH oxidase 1 enzymes at myo

258 % of myenteric neurons stained with neuronal nitric oxide synthase antibody and approximately 33% of

259 ng cell premature senescence and endothelial nitric oxide synthase downregulation.

260 l perfusion has been used to determine which nitric oxide synthase enzymes are active in discrete reg

261 Nitric oxide synthase 2/inducible nitric oxide synthase expression (determined by quantita

262 beta cells, which are mediated by inducible nitric oxide synthase expression and beta-cell productio

263 rotocols utilizing intravenous infusion of a nitric oxide synthase inhibitor and isovolumic haemodilu

264 (placebo) and the non-selective competitive nitric oxide synthase inhibitor N(G) -monomethyl-l-argin

265 Intravenous infusion of a nitric oxide synthase inhibitor reduced the neurovascula

266 and improve vascular function in endothelial nitric oxide synthase knockout (eNOS(-/-) ) mice.

267 mbers of nitrergic neurons, reduced neuronal nitric oxide synthase production, and reduced colonic ne

268 d investigated the role of 12,13-diHOME in a nitric oxide synthase type 1 deficient (NOS1(-/-)) mouse

269 osine kinase(Tek), isolectin B4, endothelial nitric oxide synthase(eNOS), von Willebrand factor(vWF),

270 helial growth factor), and eNOS (endothelial nitric oxide synthase) protein contents.

271 gressive blockade of adenosine receptors and nitric oxide synthase, and by modeling the determinants

272 hways, specifically MAPK/ERK1/2, endothelial nitric oxide synthase, and mammalian target of rapamycin

273 dase, uncoupling of endothelial and neuronal nitric oxide synthase, and vascular/brain infiltration w

274 neurons showed increased levels of inducible nitric oxide synthase, another indicator of cell damage.

275 A), an endogenous inhibitor and uncoupler of nitric oxide synthase, has gained attention as a risk fa

276 e molecules, including arginase 1, inducible nitric oxide synthase, signal transducer and activator o

277 ecrosis factor-alpha, interleukin-1beta, and nitric oxide synthase-2, highlighting the potential of V

278 ossibly by affecting the NF-kappaB-inducible nitric oxide synthase-endoplasmic reticulum stress pathw

279 alpha(+)]), and effector molecule (inducible nitric oxide synthase-positive [iNOS(+)]) responses were

280 actile inhibition via the enzyme endothelial nitric oxide synthase.

281 egregated population that expresses neuronal nitric oxide synthase.

282 n species caused by dysregulated endothelial nitric-oxide synthase (eNOS) activity is linked to vascu

283 gulate expression of the inflammatory marker nitric-oxide synthase 2.

284 levels of proinflammatory markers: inducible nitric-oxide synthase and tumor necrosis factor-alpha, w

285 ression revealed significant upregulation of nitric oxide synthetase (NOS1 and NOS3) and neuroprotect

286 lective manner, these findings indicate that nitric oxide targets the same metabolic pathways necessa

287 Fractional exhaled nitric oxide testing is recommended to assist in diagnos

288 yurea generates a protocell-mediated flux of nitric oxide that we exploit for in vitro and in vivo bl

289 (hemoglobin) and oxygen, carbon dioxide, and nitric oxide-the three-gas respiratory cycle-that insure

290 stress stimuli and haemoglobin scavenging of nitric oxide; these two regulatory factors have not been

291 paminergic neurons release both dopamine and nitric oxide to increase the flexibility of olfactory me

292 dependent NO reductases (cNOR), which reduce nitric oxide to nitrous oxide and water.

293 To investigate the contribution of nitric oxide to NVC in humans, we utilized a visual stim

294 t align in the direction of flow and produce nitric oxide under high shear stress.

295 r of exosomal nitric oxide (NO) synthase and nitric oxide was measured by using ELISAs and NO activit

296 lyzed by immunohistochemistry, and levels of nitric oxide were measured.

297 acula densa cells triggers the production of nitric oxide, which also contributes to glomerular hyper

298 truncated NOS2 protein that did not produce nitric oxide, which determined that the patient had auto

299 signals from activated T cells by releasing nitric oxide, which inhibits T cell proliferation and re

300 s novel insight into the mechanisms by which nitric oxide, which is produced in hepatocytes in respon